Acyclovir dose for suppressive therapy

Neonatal Herpes Encephalitis Newborn Infections Following the initial acyclovir therapy, infants may need additional oral acyclovir suppressive therapy for

Suppressive therapy with acyclovir, famciclovir, or valacyclovir to a high-dose suppressive valacyclovir group (1,000 mg bid) in. ART

suppressive therapy with antiviral medication such as acyclovir or valacyclovir. Usually a low dose is given daily to prevent any outbreaks

The acyclovir dose when used as suppressive therapy is 400 mg Acyclovir prophylaxis of HSV infections is of clinical value in severely immunocompromised patients

first recurrence of symptoms in favor of suppressive dosing (P 0.0001). Suppressive therapy with oral acyclovir, famciclovir or valacyclovir

Daily Suppressive Therapy: Acyclovir 400mg bid or acyclovir 200mg PO 3-5 times a day. (The goal of the 200-mg regimen is to identify the lowest dose that

by JM Baeten 2024 Cited by 30States exposed to daily HSV-2 suppressive therapy for between. 8 weeks doses of acyclovir and valacyclovir suppressive therapy select for specific

Over all, acyclovir is a safe and effective drug with acyclovir-resistant HSV in an infant on long term suppressive acyclovir therapy.

acyclovir-suppressive therapy. Thus, the low dose of acyclovir suppressive therapy did not affect the susceptibility to acyclovir or increase the fre-quency of acyclovir-resistant viruses in the geni-tal lesions. Keywords: genital herpes, herpes simplex virus, acyclovir, susceptibility Introduction 2024 International Medical Press